series-c-plus
Stage
1
Investors
About
Airsonett is a Swedish medical device company focused on the non-pharmaceutical treatment of allergic asthma and atopic dermatitis through its patented Temperature-controlled Laminar Airflow (TLA) technology, offering a device that creates a clean air zone during sleep to reduce allergen exposure.
Explore Airsonett's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.